Navigation Links
Salivary Diagnostics from Salimetrics Support daacro, a German Contract Research Organization, in neuropattern™ Customization
Date:1/26/2017

daacro’s Saliva Lab Trier, where new promising biomarkers will be searched and analyzed, will do a major part of the work for this project. daacro’s Saliva Lab is a Salimetrics Center of Excellence Laboratory and closely cooperates with Salimetrics, who is widely regarded as a global leader in developing assays for salivary bioscience.

The ActiveNutraLife approach combines a nutraceutical supplementation, a remotely accessible adapted physical activity program and a personalized stress and fatigue diagnostic tool, allowing acceleration and monitoring of the individual recovery. An “ActiveNutraLife” kit containing these services will be offered by means of the web and is of interest to health insurance providers.

To achieve this aim, daacro partners with two French companies – Bionov, responsible for the nutraceutical supplementation (a unique melon extract) and V@si, responsible for the adapted physical activity program.

daacro’s responsibility in this project is the development of the diagnostic tool which will be an offspring of daacro’s neuropattern™. neuropattern™ is an individualized diagnostic tool for stress related disorders, which allows differentiation between 13 stress-related endophenotypes called “neuropattern”. The adapted version “HEMO-neuropattern” will concentrate on fatigue-related endophenotypes.

In a first step, daacro will work on adapting and further developing the existing neuropattern™ diagnostic and on finding new biomarkers to better identify subgroups of haematological cancer patients (“HEMO-neuropattern”). Next, in a clinical trial performed by Hospital CHU Montpellier and further sites in South France, “HEMO-neuropattern” will be tested on efficacy of its personalized recommendations for better management of chemotherapy-induced side effects.

About Salimetrics:

Salimetrics’ assay kits and CLIA-certified testing services are used to measure salivary analytes related to stress, behavior and development, inflammation, sleep, reproduction, health and immune function. Founded in 1998 by Douglas A. Granger, Ph.D., Salimetrics, LLC supports CROs, pharmaceuticals, academic researchers and the immunodiagnostic industry around the world with innovative immunoassay products, non-invasive saliva collection methods, and laboratory testing services.

About neuropattern™

neuropattern™ is a diagnostic test that was developed in Trier, Germany. It provides a comprehensive assessment of neuroendocrine, psychosocial, and physical health interactions that emanate from the brain and body under stress. neuropattern™ is used to differentiate endophenotypes in patients with similar symptomatology and thus, this the procedure is particularly suited for individualized diagnostics and pharmacogenetic studies.

Read the full story at http://www.prweb.com/releases/saliva-diagnostics/neuropattern/prweb13998202.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. The First Commercial Salivary Uric Acid Assay Kit is Now Available from Salimetrics
2. Salimetrics Supports Advancements in Drug Development with Salivary Biomarkers and Analytes for Clinical Trials
3. Salimetrics Launches a Better Salivary IL-6 ELISA/EIA Kit
4. Salimetrics Launches a Faster, More Accurate, Salivary Melatonin Assay
5. Nanomedical Diagnostics to Present Field Effect Biosensing for Fragment-Based Drug Discovery at SLAS 2017
6. Interpace Diagnostics Announces $4.0 Million Registered Direct Offering of Common Stock
7. SQI Diagnostics Announces Change to its Board of Directors
8. Cancer Diagnostics Market is Predicted to Grow at a CAGR of 12% from 2016 to 2022
9. Global Molecular Diagnostics Research Report 2017: Focus on Technologies, Applications, Regulations, Markets and Companies to 2025 - Research and Markets
10. Dr. Michael A. Pfaller of T2 Biosystems to Discuss the Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship in New Webinar
11. SQI Diagnostics Reports Fourth Quarter and Fiscal 2016 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... United States multicenter, prospective clinical study that demonstrates the accuracy of the ... of identifying clinically significant acute bacterial and viral respiratory tract infections by ...
(Date:10/12/2017)... (PRWEB) , ... October 12, ... ... ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed for ... complexity. Named in honor of pioneering researcher Rosalind Franklin, who made a ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a basic first ... eye at a time. So which eye do you rinse first if a dangerous substance ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its ...
(Date:10/11/2017)...  VMS BioMarketing, a leading provider of patient support solutions, ... Educator (CNE) network, which will launch this week. The VMS ... care professionals to enhance the patient care experience by delivering ... health care professionals to help women who have been diagnosed ... ...
Breaking Biology Technology:
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... Report on Form 10-K on Thursday April 13, 2017 with the ... The ... section of the Company,s website at http://www.nxt-id.com  under "SEC Filings," ... 2016 Year Highlights: Acquisition of ...
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
Breaking Biology News(10 mins):